More than 1,150 global healthcare leaders and personnel registered for Safe in Commons online conference, The Unfinished Agenda: Addressing the Challenges, as an ongoing indication of the healthcare industry demand for unification surrounding protection from needlestick and sharps injuries.
As part of the non-profit organizations on-going series of events, Safe in Common convened a panel of experts on Feb. 5, 2013Â for an interactive discussion on how to minimize the risk of sharps-related injuries within the operating room (OR) and alternate care settings, the development of optimal selection criteria for engineered sharps devices, and the improved use of data to set priorities and improve exposure control plans. The event was a prime opportunity to field a series of topical polls designed to gauge the state of needlestick and sharps injury prevention. Among the findings was confirmation of industry estimates that less than one-quarter of operating rooms are standardized on blunt suture needles and that surgeons dominate the device buying decision.
When asked through an online poll during the event, more than 37 percent of attendees said the greatest influence for selection of engineering controls for use in the OR was surgeons, followed by collaborative process with all at-risk personnel represented (33.6 percent), purchasing/administration (15.7 percent), nursing (9.7 percent) and anesthesia (4.1 percent).Â
In reviewing the poll results, Mary Foley, PhD, chairperson of Safe in Common, says, The results of these events shows us that we are unifying and that awareness surrounding the need for needlestick- and sharps-related injury prevention is spreading rapidly throughout the healthcare industry, but adoption of safety-engineered devices is slow, and too many of us continue to face daily harm.
Other practices recommended by a panel of experts from the Association of periOperative Registered Nurses (AORN) include double-gloving, the use of a neutral zone for passing, and the use of safety-engineered devices, yet none of these practices were the being deployed by a majority of respondents.
Nearly 62 percent of the attendees said they are using sharps injury data in making purchasing decisions for medical devices. In a sign of progress, some 61 percent said that in 2012 they participated in an engineering control evaluation and/or annual exposure control plan review.
Foley says, Although 61 percent of the participants have been involved, we still have a lot of work to do to improve those numbers and grow awareness to 85 percent or greater which is all evidence of the need to support the Unfinished Agenda Online Conference series.
An interactive edition of the online conference is available for replay on Safe In Commons YouTube channel. The event also featured unprecedented participation from a panel of experts:
 Mary Ogg, MSN, RN, CNOR and Perioperative Nursing Specialist from The Association of Perioperative Registered Nurses (AORN)
 Donna A. Ford, MSN, RN-BC, CNOR, Nursing Education Specialist, Division of Surgical Services, Department of Nursing, and an Assistant Professor of Nursing, College of Medicine, Mayo Clinic; AORN National Clinical Nursing Practice Committee
 Deborah Spratt MPA, BSN, RN, CNOR, NEA-BC, CRCST, CHL, Manager of Sterile Processing at the Canandaigua VAMC in Canandaigua NY; AORN President
 Angela Laramie, Epidemiologist with the Sharps Injury Surveillance Project in the Occupational Health Surveillance Program at the Massachusetts Department of Public Health
 June M. Fisher, MD, Clinical Professor in the Division of Occupational and Environmental Medicine at the University of California San Francisco (UCSF) School of Medicine
 Elise Handelman, Former Director of the Office of Occupational Health Nursing at the Occupational Safety and Health Administration (OSHA)
 William Hyman, Professor Emeritus of Biomedical Engineering, Texas A&M University, past President of the Healthcare Technology Foundation
The key opinion leaders discussed a wide range of topics surrounding existing resources that can help prevent injuries as well as offered best practices to foster a culture of safety. While the panelists were able to weigh in on many of the questions, the majority of the inquiries are being answered by experts on Safe in Commons website: www.safeincommon.org/blog.
The online conference series is part of Safe in Commons ongoing efforts to spark innovation, awareness and change across the healthcare spectrum, with a core focus on the Needlestick Safety Pledge. The events are presented as part of Safe in Commons continued mission to unify and educate people about the risks of needlestick and sharps-related injuries.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.